Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in …
$0.29-3.53%
报价 2026-11-06
市值
$40.6M
EV
$73.5M
PE (TTM)
–
预期 PE (FY2026)
28.9x
52 周区间距高点 -64.3%
$0.28$0.81
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| XTNTXtant Medical Holdings, Inc. | $40.6M | -3.5% | -22.6% | 59.4% | – | – | – | |
| RCELAVITA Medical, Inc. | $412.1M | +5.8% | – | 81.6% | – | – | – | |
| APYXApyx Medical Corporation | $123.4M | -4.2% | +14.2% | 34.5% | – | – | – | |
| VANIVivani Medical, Inc. | $96.5M | +2.9% | -100.0% | 0% | – | – | – | |
| LUCDLucid Diagnostics Inc. | $76M | +2.0% | +60.9% | -25.8% | – | – | – | |
| EXOZeXoZymes, Inc. | $40.8M | +7.1% | – | 0% | – | – | – | |
| NSPRInspireMD, Inc. | $32.4M | +8.9% | – | 18.1% | – | – | – | |
| RPIDRapid Micro Biosystems, Inc. | $29.3M | +3.4% | +17.6% | 12.4% | – | – | – | |
| ESLAEstrella Immunopharma, Inc. | $16.3M | -8.5% | – | 0% | – | – | – | |
| 同行中位数 | – | – | +15.9% | 6.2% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。